Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Dexcom Q4 2025 Earnings Call - G7 15-Day rollout lifts margins as Medicare Type 2 non-insulin coverage looms
Dexcom closed 2025 on a healthier note: Q4 revenue rose 13% to $1.26 billion, full-year results beat the high end of guidance, and the company finished with about $2 billion in cash after settling con...
- Q4 2025 revenue $1.26 billion, up 13% year over year; U.S. revenue $892 million, international $368 million (18% growth).
- Full-year revenue finished above the high end of Dexcom's most recent guidance; 2026 revenue guide is $5.16 billion to $5.25 billion, +11% to +13%.
- Gross profit in Q4 was $799.8 million, or 63.5% of revenue, a ~400 basis point improvement year over year and more than 200 basis points sequentially. 2026 gross margin guidance is 63% to 64%, with management targeting 200 to 300 basis points of expansion.
- +12 more takeaways
Bio-Rad Q4 2025 Earnings Call - ddPCR Traction and Supply-Chain Margin Pressures
Bio-Rad closed 2025 with mixed execution. Revenue was essentially flat for the year at $2.583 billion, Q4 sales rose to $693 million driven by diagnostics, while life science remained soft as academic...
- Q4 2025 net sales were $693 million, up 3.9% reported and up 1.7% on a currency neutral basis versus Q4 2024.
- Full year 2025 revenue was $2.583 billion, essentially flat year-over-year on a currency neutral basis.
- Life Science Q4 sales were $268 million, down 2.6% reported and down 4% currency neutral, hurt by weak academic and early-stage biotech instrument demand.
- +13 more takeaways
Applied Materials Q1 FY2026 Earnings Call - AI-Led Ramp Means >20% Semi-Equipment Growth, Clean-Room Capacity Now the Governor
Applied reported a clean beat in Q1 FY2026 with $7.0 billion revenue and $2.38 non-GAAP EPS, then doubled down on a very bullish setup: the company expects its semiconductor equipment business to grow...
- Q1 results: revenue $7.0 billion (upper end of guidance), non-GAAP EPS $2.38, non-GAAP gross margin 49.1% (up 20 bps YoY).
- Company guidance for Q2: revenue $7.65 billion ± $500 million; non-GAAP EPS $2.64 ± $0.20; non-GAAP gross margin ~49.3%; non-GAAP OpEx ~ $1.415 billion.
- Applied expects its semiconductor equipment business to grow more than 20% in calendar 2026, with demand weighted to the second half of the year and momentum expected to carry into 2027.
- +17 more takeaways
Capstone Green Energy Q3 FY2026 Earnings Call - Record Adjusted EBITDA and ramp toward data center megawatt opportunity
Capstone reported a clear operational inflection in Q3 FY2026: revenue of $26.8 million, up 33% year over year, and a record adjusted EBITDA of $5.1 million, marking the seventh straight quarter of po...
- Q3 revenue $26.8 million, up 33% year over year; year-to-date revenue $83 million, up 42% versus prior year.
- Record quarterly adjusted EBITDA of $5.1 million, seventh consecutive quarter of positive adjusted EBITDA, YTD adjusted EBITDA > $12.3 million, exceeding all of FY2025 by over $4 million.
- Gross profit $10.4 million and gross margin expanded to 39%, a 14 point improvement versus prior year, driven by favorable product mix, DFMA cost-outs, and the Cal Microturbine distributor acquisition.
- +12 more takeaways
10x Genomics Q4 2025 Earnings Call - Flex APEX adoption drives consumables volume even as instrument sales lag amid tight research funding
10x Genomics closed Q4 with $166 million in revenue and finished 2025 at $599 million of revenue, excluding $44 million of upfront patent settlement revenue. The quarter showed a tale of two businesse...
- Q4 revenue $166 million, beating the high end of guidance; full year 2025 revenue $599 million, excluding $44 million of upfront patent litigation settlement revenue.
- Company set 2026 revenue guidance at $600 million to $625 million, which implies roughly 0% to 4% growth year over year when excluding the 2025 settlement revenue.
- Consumables show strength: total consumables revenue up 6% in Q4; single-cell consumables up 3% with reaction volumes growing double digits, and spatial consumables up 14% driven by Xenium.
- +12 more takeaways
Alliance Entertainment Q2 FY2026 Earnings Call - Margin expansion validates shift to premium physical media, collectibles, and authenticated platform
Alliance delivered a quarter that reads like a strategic pivot in progress. Revenue dipped to $369 million as lower-margin categories softened, but management pushed a deliberate tradeoff and earned i...
- Net revenue for Q2 FY2026 was $369 million, down from $394 million a year ago, driven by softness in lower-margin categories and deliberate mix shifts.
- Gross profit rose to $47.1 million and gross margin expanded 210 basis points to 12.8%, driven by a move into premium physical media and collectibles.
- Net income increased to $9.4 million, or $0.18 per diluted share, versus $7.1 million, or $0.14, in the prior year quarter.
- +15 more takeaways
Artivion Q4 2025 Earnings Call - AMDS, On-X, and NEXUS clinical momentum sets up double-digit growth with mid-2026 PMA milestones
Artivion closed 2025 with a clean beat on both growth and margin expansion, driven by a stent graft rebound, accelerating On-X share gains, and a pair of favorable clinical readouts that put regulator...
- Q4 adjusted revenues were $118.3 million, full year adjusted revenues were $443.6 million, up 13% on an adjusted constant currency basis for 2025.
- Adjusted EBITDA grew 26% in 2025, driving a full-year adjusted EBITDA margin of 20.2%, and Q4 adjusted EBITDA was $22.7 million with a 19.2% margin.
- Stent grafts led Q4 growth, up 36% year over year on a constant currency basis, driven by AMDS in the U.S., international strength, and an easier comp from last year’s cyber incident.
- +14 more takeaways
Wynn Resorts Q4 2025 Earnings Call - Al Marjan top-out accelerates shift to majority non-US-dollar revenue
Wynn closed Q4 with healthy momentum across Las Vegas, Macau, and Boston, while execution on Wynn Al Marjan Island moved into high gear with the tower topped out and interior fit-out underway. Managem...
- Wynn topped out the Wynn Al Marjan Island tower at the 70th floor, with interior fit-out underway and exterior glass about 80% complete.
- Management expects the company to move toward generating over 55% of revenues in non-US-dollar markets as Al Marjan and other international assets ramp.
- Q4 adjusted property EBITDA: Wynn Las Vegas ~$241 million, Wynn Macau ~$271 million, Encore Boston Harbor ~$57 million; consolidated adjusted property EBITDA exceeded $2.2 billion for the year.
- +13 more takeaways
Expedia Group Q4 2025 Earnings Call - Nearly 4-Point Margin Expansion Fueled by B2B, AI and Marketing Discipline
Expedia closed 2025 with clear operational momentum: bookings and revenue rose 11% year-over-year, booked room nights were up 9%, and adjusted EBITDA margin expanded nearly 4 percentage points to 24% ...
- Q4 topline: gross bookings and revenue both grew 11% year-over-year, to $27.0 billion and $3.5 billion respectively.
- Adjusted EBITDA was $848 million, a 24% margin, roughly a 4 percentage point expansion versus prior year.
- Booked room nights rose 9% YoY, with high single-digit growth in the U.S. and low double-digit growth in EMEA; rest of world growth slowed due to geopolitical headwinds in Asia.
- +13 more takeaways
SPS Commerce Q4 2025 Earnings Call - 100th Consecutive Revenue Growth, AI Launch and Revenue Recovery Headwinds
SPS Commerce celebrated its 100th consecutive quarter of revenue growth while navigating mixed signals: solid profitability and cash returns to shareholders, offset by near-term demand softness and re...
- SPS hit its 100th consecutive quarter of revenue growth, a headline milestone anchored to long-term network strength.
- Q4 2025 revenue was $192.7 million, up 13% year-over-year; recurring revenue for Q4 grew 14% year-over-year.
- Full-year 2025 revenue reached $751.5 million, up 18%; recurring revenue grew 20% and adjusted EBITDA for the year rose 24% to $231.4 million.
- +12 more takeaways